Life Sciences
-
UH Ventures promotes Kipum Lee to president
UH Ventures has selected Kipum Lee as its new president, succeeding David Sylvan, who will focus on his role with University Hospitals itself.
-
Next Ventures inks strategic partnership with OHSU
The venture capital firm has closed its second fund at $60 million and signed a strategic deal with Oregon Health & Science University.
-
Friday Five: Agate Sensors, Detechgene, Data Revival, SenseAI Vision, xCystence Bio
The Friday Five series is back after the summer break, and we’re kicking things off with an array of spinouts that just so happen to all be operating within the life sciences.
-
Portal Innovations kicks off $100 million Velocity Fund
Portal Innovations, established by John Flavin who previously set up the Polsky Center, partners with institutions like UChicago to support spinouts.
-
CIC launches £250 million Fund III, commits £100 million to Cambridge spinouts
Cambridge Innovation Capital will put at least £100 million into University of Cambridge spinouts as part of its third fund.
-
Brandon Capital collects A$439 million for sixth fund
Australasian life sciences VC Brandon Capital has a partnership with more than 50 research institutions that provide access to deals.
-
UTEC unveils Fund 6, reaches AuM of more than $1 billion
University of Tokyo Edge Capital Partners has raised ¥47 billion ($326 million) for its sixth fund, its largest to date.
-
Catalio closes Nexus Fund IV with $400 million
Catalio Capital Management specialises in launching and investing in life sciences spinouts through a network of researchers that act as venture partners.
-
David O’Neill departs from FACIT
David O’Neill had been president of oncology-focused commercialisation firm Fight Against Cancer Innovation Trust since 2018. Peter Goodhand replaces him.
-
Biotope Ventures reaches 5€ million first close for Fund II
Biotope Ventures, the accelerator and investment arm for Belgian research institute VIB, has raised 5€ million towards a 9€ million goal for its second fund.
-
Friday Five: Astratus, Hirundo, Lembas, OrisDX, and Somnee
We take a look at some of the early-stage spinouts that caught our eye. This time: Astratus, Hirundo, Lembas, OrisDX and Somnee.
-
Longview Innovation joins Anzu, forming the North America University Innovations Fund
Longview Innovation is joining forces with Anzu Partners and launching the North America University Innovations Fund.
-
Cancer Focus Fund targets $250m for second vehicle
The Cancer Focus Fund is affiliated with the University of Texas MD Anderson Cancer Center and is targeting about five times as much cash for Fund II.
-
Winsome Cheung: Startups, here’s what to know when negotiating with big pharma
Winsome Cheung is a partner at Covington who helps biotech startups and big pharma negotiate deals. Here, she shares what to look out for in contracts.